Friday, 29 March 2024


China Biologic raises equity share to 76%

09 September 2014 | News | By BioSpectrum Bureau

China Biologic is a plasma-based biopharmaceutical company

China Biologic is a plasma-based biopharmaceutical company

Singapore: China Biologic Products has acquired an additional 19.84 percent equity interest in Guizhou Taibang Biological Products, raising shares from 56.39 percent to 76.23 percent.

China Biologic is a plasma-based biopharmaceutical company in China. The company's products are used as critical therapies during medical emergencies and for the prevention and treatment of life-threatening diseases and immune-deficiency related diseases.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account